• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bat3 通过抑制 Tim-3 介导的细胞死亡和衰竭来促进 T 细胞反应和自身免疫。

Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion.

机构信息

Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Nat Med. 2012 Sep;18(9):1394-400. doi: 10.1038/nm.2871.

DOI:10.1038/nm.2871
PMID:22863785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3491118/
Abstract

T cell immunoglobulin and mucin domain–containing 3 (Tim-3) is an inhibitory receptor that is expressed on exhausted T cells during infection with HIV-1 and hepatitis C virus. By contrast, Tim-3 expression and function are defective in multiple human autoimmune diseases. However, the molecular mechanisms modulating Tim-3 function are not well understood. Here we show that human leukocyte antigen B (HLA-B)-associated transcript 3 (Bat3) binds to, and represses the function of, Tim-3. Bat3 protects T helper type 1 (TH1) cells from galectin-9–mediated cell death and promotes both proliferation and proinflammatory cytokine production. Bat3-deficient T cells have elevated expression of exhaustion-associated molecules such as Tim-3, Lag3, Prdm1 and Pbx3, and Bat3 knockdown in myelin-antigen–specific CD4+ T cells markedly inhibits the development of experimental autoimmune encephalomyelitis while promoting the expansion of a dysfunctional Tim-3hi, interferon-γ (IFN-γ)loCD4+ cell population. Furthermore, expression of Bat3 is reduced in exhausted Tim-3+ T cells from mouse tumors and HIV-1–infected individuals. These data indicate that Bat3 acts as an inhibitor of Tim-3–dependent exhaustion and cell death. Bat3 may thus represent a viable therapeutic target in autoimmune disorders, chronic infections and cancers.

摘要

T 细胞免疫球蛋白和粘蛋白结构域 3(Tim-3)是一种抑制性受体,在感染 HIV-1 和丙型肝炎病毒时表达于耗尽的 T 细胞上。相比之下,Tim-3 的表达和功能在多种人类自身免疫性疾病中存在缺陷。然而,调节 Tim-3 功能的分子机制尚不清楚。在这里,我们表明人类白细胞抗原 B(HLA-B)相关转录物 3(Bat3)与 Tim-3 结合并抑制其功能。Bat3 可保护辅助性 T 细胞 1(TH1)细胞免受半乳糖凝集素-9 介导的细胞死亡,并促进增殖和促炎细胞因子的产生。Bat3 缺陷型 T 细胞高表达衰竭相关分子,如 Tim-3、Lag3、Prdm1 和 Pbx3,Bat3 在髓鞘抗原特异性 CD4+T 细胞中的敲低可显著抑制实验性自身免疫性脑脊髓炎的发展,同时促进功能失调的 Tim-3hi、干扰素-γ(IFN-γ)loCD4+细胞群的扩张。此外,在来自小鼠肿瘤和 HIV-1 感染个体的耗尽的 Tim-3+T 细胞中,Bat3 的表达减少。这些数据表明,Bat3 作为 Tim-3 依赖性衰竭和细胞死亡的抑制剂发挥作用。Bat3 因此可能成为自身免疫性疾病、慢性感染和癌症的可行治疗靶点。

相似文献

1
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion.Bat3 通过抑制 Tim-3 介导的细胞死亡和衰竭来促进 T 细胞反应和自身免疫。
Nat Med. 2012 Sep;18(9):1394-400. doi: 10.1038/nm.2871.
2
A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis.TIM-3/GAL-9/BAT3信号通路在多发性硬化临床表型决定中的作用。
FASEB J. 2014 Nov;28(11):5000-9. doi: 10.1096/fj.14-258194. Epub 2014 Aug 4.
3
Down-regulation of HLA-B-associated transcript 3 impairs the tumoricidal effect of natural killer cells through promoting the T cell immunoglobulin and mucin domain-containing-3 signaling in a mouse head and neck squamous cell carcinoma model.在小鼠头颈鳞状细胞癌模型中,HLA - B相关转录本3的下调通过促进含T细胞免疫球蛋白和粘蛋白结构域3信号传导来损害自然杀伤细胞的杀瘤效应。
Immunobiology. 2022 Jan;227(1):152127. doi: 10.1016/j.imbio.2021.152127. Epub 2021 Jul 30.
4
Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell function.Tim-3 衔接蛋白 Bat3 作为一种内源性调节因子,可调控耐受原性树突状细胞的功能。
Sci Immunol. 2022 Mar 11;7(69):eabm0631. doi: 10.1126/sciimmunol.abm0631.
5
A Deficit of CEACAM-1-Expressing T Lymphocytes Supports Inflammation in Primary Progressive Multiple Sclerosis.缺乏表达 CEACAM-1 的 T 淋巴细胞会支持原发性进行性多发性硬化症的炎症反应。
J Immunol. 2019 Jul 1;203(1):76-83. doi: 10.4049/jimmunol.1801625. Epub 2019 May 29.
6
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.癌胚抗原相关细胞黏附分子1(CEACAM1)调节T细胞免疫球蛋白黏蛋白-3(TIM-3)介导的耐受性和耗竭。
Nature. 2015 Jan 15;517(7534):386-90. doi: 10.1038/nature13848. Epub 2014 Oct 26.
7
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.Tim-3/galectin-9 信号通路介导 T 细胞功能障碍,并预测乙型肝炎病毒相关性肝细胞癌患者的预后不良。
Hepatology. 2012 Oct;56(4):1342-51. doi: 10.1002/hep.25777.
8
Expression Analysis of Fyn and Bat3 Signal Transduction Molecules in Patients with Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病患者中 Fyn 和 Bat3 信号转导分子的表达分析。
Asian Pac J Cancer Prev. 2020 Sep 1;21(9):2615-2621. doi: 10.31557/APJCP.2020.21.9.2615.
9
TIM-3 does not act as a receptor for galectin-9.TIM-3 不作为半乳糖凝集素-9 的受体。
PLoS Pathog. 2013 Mar;9(3):e1003253. doi: 10.1371/journal.ppat.1003253. Epub 2013 Mar 21.
10
Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice.T 细胞免疫球蛋白黏蛋白 1(Tim-1)黏蛋白结构域突变小鼠调节性 B 细胞功能缺陷及全身性自身免疫的发生。
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12105-10. doi: 10.1073/pnas.1120914109. Epub 2012 Jul 5.

引用本文的文献

1
Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models.在免疫治疗难治性黑色素瘤模型中鉴定具有活性的基于抗TIM-3的检查点抑制剂组合。
J Immunother Cancer. 2025 Aug 18;13(8):e012011. doi: 10.1136/jitc-2025-012011.
2
High-throughput discovery of transmembrane helix dimers from human single-pass membrane proteins with TOXGREEN sort-seq.利用TOXGREEN分选测序技术从人类单次跨膜蛋白中高通量发现跨膜螺旋二聚体。
bioRxiv. 2025 May 11:2025.04.22.650048. doi: 10.1101/2025.04.22.650048.
3
Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective.

本文引用的文献

1
Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways.磷酸酪氨酸依赖性 Tim-3 与 T 细胞受体信号通路的偶联。
Mol Cell Biol. 2011 Oct;31(19):3963-74. doi: 10.1128/MCB.05297-11. Epub 2011 Aug 1.
2
Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease.克罗恩病患者黏膜辅助性T1细胞上T细胞免疫球蛋白黏蛋白结构域-3的上调失调
Scand J Gastroenterol. 2011 Jun;46(6):701-9. doi: 10.3109/00365521.2011.568518. Epub 2011 Apr 5.
3
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia.
从分子角度看癌症治疗中使用免疫检查点抑制剂(ICI)和抗血管生成药物的基本原理。
Clin Exp Med. 2025 Jul 8;25(1):238. doi: 10.1007/s10238-025-01751-7.
4
Controlling T cell-tumor cell interaction with a biomimetic physical barrier for cancer immunotherapy.利用仿生物理屏障控制T细胞与肿瘤细胞的相互作用以进行癌症免疫治疗。
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2500589122. doi: 10.1073/pnas.2500589122. Epub 2025 Jul 8.
5
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine.B细胞淋巴瘤免疫治疗的新视野:从免疫检查点到精准医学
Neoplasia. 2025 Jun 30;67:101206. doi: 10.1016/j.neo.2025.101206.
6
Neuropilin-2 functions as a coinhibitory receptor to regulate antigen-induced inflammation and allograft rejection.神经纤毛蛋白-2作为一种共抑制受体发挥作用,以调节抗原诱导的炎症和同种异体移植排斥反应。
J Clin Invest. 2025 Jul 1;135(13). doi: 10.1172/JCI172218.
7
Negative Immune Checkpoint Inhibitors.阴性免疫检查点抑制剂
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
8
Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma (ccRCC).透明细胞肾细胞癌(ccRCC)中的免疫检查点抑制剂
Int J Mol Sci. 2025 Jun 11;26(12):5577. doi: 10.3390/ijms26125577.
9
Anti-atherogenic immune checkpoint TIM-3 as a promising pharmacologic target toward ischemic heart diseases: a prospective review.抗动脉粥样硬化免疫检查点TIM-3作为缺血性心脏病的一个有前景的药理学靶点:前瞻性综述
Mol Biol Rep. 2025 Jun 23;52(1):623. doi: 10.1007/s11033-025-10729-3.
10
Unravelling T cell exhaustion through co-inhibitory receptors and its transformative role in cancer immunotherapy.通过共抑制受体解析T细胞耗竭及其在癌症免疫治疗中的变革性作用。
Clin Transl Med. 2025 May;15(5):e70345. doi: 10.1002/ctm2.70345.
Tim-3 和 PD-1 的共表达鉴定了患有播散性急性髓系白血病的小鼠 CD8+ T 细胞耗竭表型。
Blood. 2011 Apr 28;117(17):4501-10. doi: 10.1182/blood-2010-10-310425. Epub 2011 Mar 8.
4
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.靶向 Tim-3 和 PD-1 通路逆转 T 细胞耗竭,恢复抗肿瘤免疫。
J Exp Med. 2010 Sep 27;207(10):2187-94. doi: 10.1084/jem.20100643. Epub 2010 Sep 6.
5
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients.Tim-3 和 PD-1 表达的上调与黑色素瘤患者肿瘤抗原特异性 CD8+ T 细胞功能障碍有关。
J Exp Med. 2010 Sep 27;207(10):2175-86. doi: 10.1084/jem.20100637. Epub 2010 Sep 6.
6
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.慢性病毒感染过程中 Tim-3 和 PD-1 在 CD8 T 细胞耗竭中的协同作用。
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14733-8. doi: 10.1073/pnas.1009731107. Epub 2010 Aug 2.
7
Constitutively active Lck kinase in T cells drives antigen receptor signal transduction.T细胞中组成型激活的Lck激酶驱动抗原受体信号转导。
Immunity. 2010 Jun 25;32(6):766-77. doi: 10.1016/j.immuni.2010.05.011. Epub 2010 Jun 11.
8
Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.快速诱导多种抑制性受体导致 Friend 病毒特异性效应 CD8+ T 细胞过早耗尽。
J Immunol. 2010 May 1;184(9):4696-707. doi: 10.4049/jimmunol.0903478. Epub 2010 Mar 29.
9
T-cell exhaustion: characteristics, causes and conversion.T 细胞耗竭:特征、原因与转化。
Immunology. 2010 Apr;129(4):474-81. doi: 10.1111/j.1365-2567.2010.03255.x. Epub 2010 Feb 23.
10
Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.Th1、Th17和Th9效应细胞可诱导出具有不同病理表型的实验性自身免疫性脑脊髓炎。
J Immunol. 2009 Dec 1;183(11):7169-77. doi: 10.4049/jimmunol.0901906. Epub 2009 Nov 4.